i am on tirzepatide (Month 1) 2.5mg Tirzepatide IM - Natural Endocrinology

Understanding your options and what to expect Delivery timing and how the process works General questions before you decide Safety Considerations and When to Seek Medical Advice Retatrutide's unapproved UK status means no quality or dosing guarantees exist outside trials

Among the most notable side effects are nausea, vomiting, diarrhea, and stomach pain upon starting the drug treatment

The rules differ by product

Greater Weight Loss Clinical Trial Data: In the Phase 2 TRIUMPH-1 study , retatrutide achieved unprecedented levels of weight loss : Up to 24.2% average total body weight loss at 48 weeks Over 26% weight loss at the highest dose (12 mg weekly) In comparison: Tirzepatides weight loss peaked at about 22.5% in SURMOUNT-1 at 72 weeks This suggests faster, more significant fat loss in less time with retatrutide

Direct answer: Patients may notice appetite changes, digestive adjustments, and gradual weight changes during the transition period

Tirzepatide is one of the GIP/GLP-1 dual-agonist therapies at Cosmetic Injectables Center Medspa in Sherman Oaks for adult patients meeting clinical criteria for chronic weight management or related metabolic conditions